首页 工具
登录
购物车
Fosaprepitant dimeglumine

Fosaprepitant dimeglumine

产品编号 T1790   CAS 265121-04-8
别名: 福沙匹坦二甲葡胺, L785298, 福沙吡坦二甲葡胺, MK-0517, Fosaprepitant dimeglumine salt

Fosaprepitant dimeglumine (MK-0517) 是 Aprepitant 的前药。它是一种神经激肽 1 受体拮抗剂,可用于预防化疗引起的恶心呕吐。

TargetMol的所有产品和服务仅用于科学研究,不能被用于人体,我们也不向个人提供产品和服务。
Fosaprepitant dimeglumine Chemical Structure
Fosaprepitant dimeglumine, CAS 265121-04-8
规格 价格/CNY 货期 数量
5 mg ¥ 457 现货
10 mg ¥ 625 现货
25 mg ¥ 1,298 现货
50 mg ¥ 2,243 现货
100 mg ¥ 3,717 现货
1 mL * 10 mM (in DMSO) ¥ 646 现货
千万补贴 助力科研
BCA蛋白浓度测定试剂盒限时半价
Venetoclax限时半价
MG-132限时半价
产品目录号及名称: Fosaprepitant dimeglumine (T1790)
点击图片重新获取验证码
选择批次  
纯度: 98.75%
纯度: 98%
纯度: 97.39%
更多批次查询请联系客服
生物活性
化学信息
存储 & 溶解度
参考文献
产品描述 Fosaprepitant dimeglumine (MK-0517) is the dimeglumine salt form of fosaprepitant, the water-soluble, N-phosphorylated prodrug of aprepitant, with antiemetic activity. Upon intravenous administration and rapid conversion to aprepitant, this agent binds selectively to the human substance P/neurokinin 1 (NK1) receptors in the central nervous system (CNS). This inhibits receptor binding of the endogenous substance P and prevents substance P-induced emesis.
体外活性 Fosaprepitant (MK-0517, L-758,298) is a phosphoryl prodrug for aprepitant. Aprepitant is a selective substance P (NK-1 receptor) antagonist approved as part of combination therapy with a corticosteroid and a 5-HT 3 receptor antagonist for the prevention of acute and delayed Chemotherapy-induced nausea and vomiting. [1]
体内活性 Fosaprepitant is converted to aprepitant within 30 min after intravenous administration via the action of ubiquitous phosphatases when administered intravenously. Fosaprepitant is well tolerated up to 150 mg (1 mg/ml), and Fosaprepitant 115 mg is bioequivalent in its AUC to aprepitant 125 mg. Fosaprepitant 115 mg has been submitted for FDA approval as an alternative on day 1 of a 3-day oral aprepitant regimen, with oral aprepitant administered on days 2 and 3. [1]
激酶实验 Biochemical Methods: EPZ-6438 is incubated for 30 min with 40 μL per well of 5 nM PRC2 (final assay concentration in 50 μL is 4 nM ) in 1X assay buffer (20 mM Bicine [pH 7.6], 0.002% Tween-20, 0.005% Bovine Skin Gelatin and 0.5 mM DTT). 10 μL per well of substrate mix comprising assay buffer 3 H-SAM, unlabeled SAM, and peptide representing histone H3 residues 21-44 containing C-terminal biotin (appended to a C-terminal amide-capped lysine) are added to initiate the reaction (both substrates are present in the final reaction mixture at their respective Km values, an assay format referred to as ‘‘balanced conditions''. The final concentrations of substrates and methylation state of the substrate peptide are indicated for each enzyme Reactions are incubated for 90 min at room temperature and quenched with 10 μL per well of 600 μM unlabeled SAM, Then transferred to a 384-well flashplate and washed after 30 min.
别名 福沙匹坦二甲葡胺, L785298, 福沙吡坦二甲葡胺, MK-0517, Fosaprepitant dimeglumine salt
分子量 1004.83
分子式 C37H56F7N6O16P
CAS No. 265121-04-8

存储

Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度

DMSO: 185 mg/mL (184.1 mM)

Ethanol: < 1 mg/mL (insoluble or slightly soluble)

H2O: 124 mg/mL (123.4 mM)

溶液配制表

可选溶剂 浓度 体积 质量 1 mg 5 mg 10 mg 25 mg
DMSO / H2O 1 mM 0.9952 mL 4.976 mL 9.9519 mL 24.8798 mL
5 mM 0.199 mL 0.9952 mL 1.9904 mL 4.976 mL
10 mM 0.0995 mL 0.4976 mL 0.9952 mL 2.488 mL
20 mM 0.0498 mL 0.2488 mL 0.4976 mL 1.244 mL
50 mM 0.0199 mL 0.0995 mL 0.199 mL 0.4976 mL
100 mM 0.01 mL 0.0498 mL 0.0995 mL 0.2488 mL

TargetMol Calculator计算器

摩尔浓度计算器
稀释计算器
配液计算器
分子量计算器
=
X
X
X
=
X
=
/
g/mol

输入分子式,点击计算,可计算出产品的分子量。

TargetMol Library Books参考文献

1. Navari RM. Expert Opin Investig Drugs, 2007, 16(12), 1977-1985.
Eledoisin Kassinin acetate(63968-82-1 free base) (R)-CJ 11974 Befetupitant [Sar9,Met(O2)11]-Substance P acetate Burapitant NKP608 Hemokinin 1 (mouse) acetate(208041-90-1 free base)

相关化合物库

该产品包含在如下化合物库中:
抗癌上市药物库 抗癌临床化合物库 抗癌药物库 药物功能重定位化合物库 抑制剂库 FDA上市及药典收录分子库 NO PAINS 化合物库 抗癌化合物库 已知活性化合物库 神经信号分子库

TargetMol Calculator剂量换算

对于不同动物的给药剂量换算,您也可以参考 更多...

TargetMol Calculator 体内实验配液计算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。

第一步:请输入动物实验的基本信息
剂量
mg/kg
每只动物体重
g
给药体积
μL
动物数量
第二步:请输入动物体内配方组成,不同的产品配方组成不同,如有配方需求,可先联系我们提供正确的体内配方。
% DMSO
%
% Tween 80
% ddH2O
计算 重置

技术支持

您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。

Keywords

Fosaprepitant dimeglumine 265121-04-8 GPCR/G Protein Neuroscience Neurokinin receptor nociception NK receptor MK0517 antagonist 福沙匹坦二甲葡胺 Aprepitant L785298 Inhibitor receptor 福沙吡坦二甲葡胺 chemotherapy-induced L-785298 nausea Tachykinin receptor MK-0517 substance-P inhibit Neurokinin Receptor vomiting neuropeptide L 785298 MK 0517 Fosaprepitant dimeglumine salt inhibitor

 

TargetMol Loading
陶术
生物
TargetMol®中国区唯一合作伙伴
点击进入陶术生物官网陶术生物
联系我们
400-820-0310

上海市静安区江场三路238号8楼